We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > AstraZeneca

News List

Avara Pharmaceutical buys AstraZeneca’s Reims solid dosage facility pharmaceufical-technology
October 10, 2017
Avara Pharmaceutical Services has closed an agreement to purchase AstraZeneca’s secondary solid dosage, form-manufacturing, packaging and distribution facility located in Reims, France.
Aspen to acquire remaining rights to AstraZeneca’s anaesthetic medicines pharmaceufical-technology
September 19, 2017
Aspen Global Incorporated (AGI) has entered an agreement to acquire all the remaining rights to AstraZeneca’s established anaesthetic treatments for an upfront consideration of $555m.
Merck and AstraZeneca to develop and market lynparza for multiple cancer treatments pharmaceutical-technology
August 01, 2017
Merck has entered a global strategic oncology collaboration to jointly develop and commercialise AstraZeneca’s lynparza (olaparib) for the treatment of multiple cancer types.